{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:19:08Z","timestamp":1792531148892,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13555-020-00461-0","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:42:45Z","timestamp":1605022965000},"page":"13-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Rosacea Treatment: Review and Update"],"prefix":"10.1007","volume":"11","author":[{"given":"Hanlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1912-341X","authenticated-orcid":false,"given":"Qiuning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"461_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16305","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang H, Fang R, Tang K, Sun Q. The top 100 most cited articles in Rosacea: a bibliometric analysis. J Eur Acad Dermatol Venereol. 2020. https:\/\/doi.org\/10.1111\/jdv.16305.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"461_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.15122","volume":"176","author":"J Tan","year":"2017","unstructured":"Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431\u20138.","journal-title":"Br J Dermatol"},{"issue":"5","key":"461_CR3","doi-asserted-by":"crossref","first-page":"e13020","DOI":"10.1111\/dth.13020","volume":"32","author":"R Dursun","year":"2019","unstructured":"Dursun R, Daye M, Durmaz K. Acne and rosacea: what\u2019s new for treatment? Dermatol Ther. 2019;32(5):e13020.","journal-title":"Dermatol Ther"},{"issue":"6","key":"461_CR4","doi-asserted-by":"crossref","first-page":"e13093","DOI":"10.1111\/dth.13093","volume":"32","author":"I Trave","year":"2019","unstructured":"Trave I, Merlo G, Cozzani E, Parodi A. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites. Dermatol Ther. 2019;32(6):e13093.","journal-title":"Dermatol Ther"},{"issue":"4 Suppl","key":"461_CR5","first-page":"S17","volume":"13","author":"SM Johnson","year":"2020","unstructured":"Johnson SM, Berg A, Barr C. Managing Rosacea in the clinic: from pathophysiology to treatment\u2014a review of the literature. J Clin Aesth Dermatol. 2020;13(4 Suppl):S17-S22.","journal-title":"J Clin Aesth Dermatol"},{"issue":"1","key":"461_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40257-019-00471-5","volume":"21","author":"BM Rainer","year":"2020","unstructured":"Rainer BM, Thompson KG, Antonescu C, et al. Characterization and analysis of the skin microbiota in Rosacea: a case-control study. Am J Clin Dermatol. 2020;21(1):139\u201347.","journal-title":"Am J Clin Dermatol"},{"key":"461_CR7","doi-asserted-by":"crossref","unstructured":"Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352(8):793\u2013803.","DOI":"10.1056\/NEJMcp042829"},{"issue":"2","key":"461_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","volume":"36","author":"CS Ahn","year":"2018","unstructured":"Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36(2):81\u20136.","journal-title":"Dermatol Clin"},{"issue":"4","key":"461_CR9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"46","author":"J Wilkin","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"461_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","volume":"78","author":"RL Gallo","year":"2018","unstructured":"Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148\u201355.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"461_CR11","first-page":"70","volume":"104","author":"YA Wang","year":"2019","unstructured":"Wang YA, James WD. Update on rosacea classification and its controversies. Cutis. 2019;104(1):70\u20133.","journal-title":"Cutis"},{"issue":"3","key":"461_CR12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjd.16942","volume":"179","author":"JP Thyssen","year":"2018","unstructured":"Thyssen JP. Subtyping, phenotyping or endotyping rosacea: how can we improve disease understanding and patient care? Br J Dermatol. 2018;179(3):551\u20132.","journal-title":"Br J Dermatol"},{"key":"461_CR13","doi-asserted-by":"crossref","unstructured":"Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for Rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501\u201310.","DOI":"10.1016\/j.jaad.2020.01.077"},{"issue":"5","key":"461_CR14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","volume":"182","author":"M Schaller","year":"2020","unstructured":"Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182(5):1269\u201376.","journal-title":"Br J Dermatol"},{"issue":"11","key":"461_CR15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.14349","volume":"31","author":"F Anzengruber","year":"2017","unstructured":"Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol. 2017;31(11):1775\u201391.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"461_CR16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/1203475416650427","volume":"20","author":"Y Asai","year":"2016","unstructured":"Asai Y, Tan J, Baibergenova A, et al. Canadian clinical practice guidelines for Rosacea. J Cutan Med Surg. 2016;20(5):432\u201345.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"461_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2019.05.063","volume":"82","author":"M Schaller","year":"2020","unstructured":"Schaller M, Kem\u00e9ny L, Havlickova B, et al. A randomized phase 3b\/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. J Am Acad Dermatol. 2020;82(2):336\u201343.","journal-title":"J Am Acad Dermatol"},{"key":"461_CR18","doi-asserted-by":"crossref","unstructured":"Gold LS, Del Rosso JQ, Kircik L, et al. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials. J Am Acad Dermatol. 2020;82(5):1166\u201373.","DOI":"10.1016\/j.jaad.2020.01.043"},{"issue":"1","key":"461_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjd.17590","volume":"181","author":"EJ van Zuuren","year":"2019","unstructured":"van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 2019;181(1):65\u201379.","journal-title":"Br J Dermatol."},{"issue":"1","key":"461_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.17865","volume":"181","author":"L Le Cleach","year":"2019","unstructured":"Le Cleach L, Cribier B. New evidence but still unmet medical needs in rosacea treatment. Br J Dermatol. 2019;181(1):11\u20132.","journal-title":"Br J Dermatol"},{"key":"461_CR21","doi-asserted-by":"publisher","unstructured":"Hampton PJ. Expanding treatment options for rosacea. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.18985.","DOI":"10.1111\/bjd.18985"},{"key":"461_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02095-w","author":"G Li","year":"2020","unstructured":"Li G, Wang B, Zhao Z, et al. Excessive cleansing: an underestimating risk factor of rosacea in Chinese population. Arch Dermatol Res. 2020. https:\/\/doi.org\/10.1007\/s00403-020-02095-w.","journal-title":"Arch Dermatol Res."},{"issue":"9","key":"461_CR23","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/jdv.14922","volume":"32","author":"B Diczig","year":"2018","unstructured":"Diczig B, N\u00e9meth I, S\u00e1rdy M, P\u00f3nyai G. Contact hypersensitivity in rosacea\u2014a report on 143 cases. J Eur Acad Dermatol Venereol. 2018;32(9):e347\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"461_CR24","first-page":"141","volume":"18","author":"ZD Draelos","year":"2019","unstructured":"Draelos ZD, Gunt H, Levy SB. Natural skin care products as adjunctive to prescription therapy in moderate to severe Rosacea. J Drugs Dermatol. 2019;18(2):141\u20136.","journal-title":"J Drugs Dermatol."},{"issue":"3","key":"461_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000486688","volume":"31","author":"J Kresken","year":"2018","unstructured":"Kresken J, Kindl U, Wigger-Alberti W, Clanner-Engelshofen BM, Reinholz M. Dermocosmetics for use in Rosacea: guideline of the Society for Dermopharmacy. Skin Pharmacol Physiol. 2018;31(3):147\u201354.","journal-title":"Skin Pharmacol Physiol"},{"key":"461_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13591","author":"A Guertler","year":"2020","unstructured":"Guertler A, J\u00f8ntvedt NM, Clanner-Engelshofen BM, Cappello C, Sager A, Reinholz M. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group. J Cosmet Dermatol. 2020. https:\/\/doi.org\/10.1111\/jocd.13591.","journal-title":"J Cosmet Dermatol."},{"issue":"6","key":"461_CR27","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jocd.12889","volume":"18","author":"H Baldwin","year":"2019","unstructured":"Baldwin H, Santoro F, Lachmann N, Teissedre S. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin. J Cosmetic Dermatol. 2019;18(6):1686\u201392.","journal-title":"J Cosmetic Dermatol"},{"issue":"4","key":"461_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s13555-019-00331-4","volume":"9","author":"F Santoro","year":"2019","unstructured":"Santoro F, Lachmann N. An open-label, intra-individual study to evaluate a regimen of three cosmetic products combined with medical treatment of Rosacea: cutaneous tolerability and effect on hydration. Dermatol Ther. 2019;9(4):775\u201384.","journal-title":"Dermatol Ther"},{"issue":"1","key":"461_CR29","doi-asserted-by":"crossref","first-page":"e13203","DOI":"10.1111\/dth.13203","volume":"33","author":"H Husein-ElAhmed","year":"2020","unstructured":"Husein-ElAhmed H, Steinhoff M. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: a systematic review and meta-analysis. Dermatol Ther. 2020;33(1):e13203.","journal-title":"Dermatol Ther"},{"issue":"6","key":"461_CR30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaad.2015.09.065","volume":"74","author":"A Shemer","year":"2016","unstructured":"Shemer A, Shiri J, Mashiah J, Farhi R, Gupta AK. Topical minocycline foam for moderate to severe acne vulgaris: phase 2 randomized double-blind, vehicle-controlled study results. J Am Acad Dermatol. 2016;74(6):1251\u20132.","journal-title":"J Am Acad Dermatol"},{"key":"461_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18857","author":"G Webster","year":"2020","unstructured":"Webster G, Draelos ZD, Graber E, et al. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.18857.","journal-title":"Br J Dermatol."},{"issue":"8","key":"461_CR32","first-page":"896","volume":"146","author":"YE Zhao","year":"2010","unstructured":"Zhao YE, Wu LP, Peng Y, Cheng H. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010;146(8):896\u2013902.","journal-title":"Arch Dermatol"},{"issue":"6","key":"461_CR33","doi-asserted-by":"crossref","first-page":"e13103","DOI":"10.1111\/dth.13103","volume":"32","author":"S Jacob","year":"2019","unstructured":"Jacob S, VanDaele MA, Brown JN. Treatment of Demodex-associated inflammatory skin conditions: a systematic review. Dermatol Ther. 2019;32(6):e13103.","journal-title":"Dermatol Ther"},{"key":"461_CR34","doi-asserted-by":"crossref","unstructured":"Forton FMN, De Maertelaer V. Effectiveness of benzyl benzoate treatment on clinical symptoms and Demodex density over time in patients with rosacea and demodicosis: a real life retrospective follow-up study comparing low- and high-dose regimens. J Dermatol Treat. 2020:1\u201310.","DOI":"10.1080\/09546634.2020.1770168"},{"issue":"2","key":"461_CR35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jdv.15938","volume":"34","author":"FMN Forton","year":"2020","unstructured":"Forton FMN, De Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2020;34(2):365\u20139.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"461_CR36","first-page":"E7","volume":"101","author":"SL Sheu","year":"2018","unstructured":"Sheu SL. Treatment of melasma using tranexamic acid: what\u2019s known and what\u2019s next. Cutis. 2018;101(2):E7\u20138.","journal-title":"Cutis"},{"issue":"6","key":"461_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/DSS.0000000000001518","volume":"44","author":"HR Bala","year":"2018","unstructured":"Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg. 2018;44(6):814\u201325.","journal-title":"Dermatol Surg"},{"key":"461_CR38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","volume":"67","author":"Y Li","year":"2019","unstructured":"Li Y, Xie H, Deng Z, et al. Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. Int Immunopharmacol. 2019;67:326\u201334.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"461_CR39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1346-8138.2012.01515.x","volume":"40","author":"MS Kim","year":"2013","unstructured":"Kim MS, Chang SE, Haw S, Bak H, Kim YJ, Lee MW. Tranexamic acid solution soaking is an excellent approach for rosacea patients: a preliminary observation in six patients. J Dermatol. 2013;40(1):70\u20131.","journal-title":"J Dermatol"},{"issue":"2","key":"461_CR40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jocd.12724","volume":"18","author":"F Bageorgou","year":"2019","unstructured":"Bageorgou F, Vasalou V, Tzanetakou V, Kontochristopoulos G. The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea. J Cosmetic Dermatol. 2019;18(2):563\u20137.","journal-title":"J Cosmetic Dermatol"},{"key":"461_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.067","author":"D Jakhar","year":"2020","unstructured":"Jakhar D, Kaur I, Misri R. Topical 10% tranexamic acid for erythematotelangiectatic steriod induced rosacea. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2019.12.067.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"461_CR42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdv.14566","volume":"32","author":"L Chen","year":"2018","unstructured":"Chen L, Tsai TF. The role of \u03b2-blockers in dermatological treatment: a review. J Eur Acad Dermatol Venereol. 2018;32(3):363\u201371.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"461_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.129","author":"JGM Logger","year":"2020","unstructured":"Logger JGM, Olydam JI, Driessen RJB. Use of beta-blockers for rosacea-associated facial erythema and flushing: a systematic review and update on proposed mode of action. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.129.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"461_CR44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/ijdvl.IJDVL_220_16","volume":"83","author":"N Prabha","year":"2017","unstructured":"Prabha N, Chhabra N, Arora R. Beta-blockers in dermatology. Indian J Dermatol Venereol Leprol. 2017;83(3):399\u2013407.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"461_CR45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/09546634.2017.1360991","volume":"29","author":"K Pietschke","year":"2018","unstructured":"Pietschke K, Schaller M. Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol. J Dermatol Treat. 2018;29(3):310\u20133.","journal-title":"J Dermatol Treat"},{"key":"461_CR46","doi-asserted-by":"crossref","first-page":"106178","DOI":"10.1016\/j.intimp.2019.106178","volume":"79","author":"J Li","year":"2020","unstructured":"Li J, Yuan X, Tang Y, et al. Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol. 2020;79:106178.","journal-title":"Int Immunopharmacol"},{"key":"461_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.05.050","author":"B Wang","year":"2020","unstructured":"Wang B, Yuan X, Huang X, et al. Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: a multi-center, randomized, double-blind, double-dummy, pilot study. J Amer Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.050.","journal-title":"J Amer Acad Dermatol."},{"issue":"5","key":"461_CR48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14764172.2018.1528371","volume":"21","author":"BY Kim","year":"2019","unstructured":"Kim BY, Moon HR, Ryu HJ. Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea. J Cosmetic Laser Ther. 2019;21(5):291\u20136.","journal-title":"J Cosmetic Laser Ther"},{"issue":"1","key":"461_CR49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09546634.2019.1580669","volume":"31","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Jiang S, Lu Y, et al. A decade retrospective study of light\/laser devices in treating nasal rosacea. J Dermatol Treat. 2020;31(1):84\u201390.","journal-title":"J Dermatol Treat"},{"issue":"1","key":"461_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10103-018-2606-6","volume":"34","author":"Y Kapicioglu","year":"2019","unstructured":"Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci. 2019;34(1):93\u20138.","journal-title":"Lasers Med Sci"},{"issue":"4","key":"461_CR51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4103\/0378-6323.82420","volume":"77","author":"F Baglieri","year":"2011","unstructured":"Baglieri F, Scuderi G. Treatment of recalcitrant granulomatous rosacea with ALA-PDT: report of a case. Indian J Dermatol Venereol Leprol. 2011;77(4):536.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"461_CR52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/14764172.2018.1502455","volume":"21","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen L, Zhang Y, Gao X, Wu Y, Chen H. Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea. J Cosmetic Laser Ther. 2019;21(4):196\u2013200.","journal-title":"J Cosmetic Laser Ther"},{"key":"461_CR53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pdpdt.2018.08.005","volume":"24","author":"L Fan","year":"2018","unstructured":"Fan L, Yin R, Lan T, Hamblin MR. Photodynamic therapy for rosacea in Chinese patients. Photodiagn Photodyn Ther. 2018;24:82\u20137.","journal-title":"Photodiagn Photodyn Ther"},{"key":"461_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23253","author":"EA Tanghetti","year":"2020","unstructured":"Tanghetti EA, Goldberg DJ, Dover JS, et al. Oxymetazoline and energy-based therapy in patients with Rosacea: evaluation of the safety and tolerability in an open-label, interventional study. Lasers Surg Med. 2020. https:\/\/doi.org\/10.1002\/lsm.23253.","journal-title":"Lasers Surg Med."},{"key":"461_CR55","doi-asserted-by":"crossref","unstructured":"Suggs AK, Macri A, Richmond H, Munavalli G, Friedman PM. Treatment of erythematotelangiectatic Rosacea with pulsed-dye laser and oxymetazoline 1.0% cream: a retrospective study. Lasers Surg Med. 2020;52(1):38\u201343.","DOI":"10.1002\/lsm.23176"},{"issue":"6","key":"461_CR56","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/jocd.12952","volume":"18","author":"J Deaver Peterson","year":"2019","unstructured":"Deaver Peterson J, Katz TM. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy. J Cosmetic Dermatol. 2019;18(6):1758\u201364.","journal-title":"J Cosmetic Dermatol"},{"issue":"9","key":"461_CR57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DSS.0000000000001819","volume":"45","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Kim JH, Cheon HI, et al. Assessment of skin physiology change and safety after intradermal injections with botulinum toxin: a randomized, double-blind, placebo-controlled, split-face pilot study in rosacea patients with facial erythema. Dermatol Surg. 2019;45(9):1155\u201362.","journal-title":"Dermatol Surg"},{"key":"461_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.014","author":"J Bharti","year":"2018","unstructured":"Bharti J, Sonthalia S, Jakhar D. Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea. J Am Acad Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.014.","journal-title":"J Am Acad Dermatol."},{"key":"461_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13976","author":"F Al-Niaimi","year":"2020","unstructured":"Al-Niaimi F, Glagoleva E, Araviiskaia E. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing. Dermatol Ther. 2020. https:\/\/doi.org\/10.1111\/dth.13976.","journal-title":"Dermatol Ther."},{"issue":"6","key":"461_CR60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1203475419867611","volume":"23","author":"A Amir Ali","year":"2019","unstructured":"Amir Ali A, Vender R, Vender R. The role of IL-17 in papulopustular Rosacea and future directions. J Cutan Med Surg. 2019;23(6):635\u201341.","journal-title":"J Cutan Med Surg"},{"key":"461_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19172","author":"AM Kumar","year":"2020","unstructured":"Kumar AM, Chiou AS, Shih YH, Li S, Chang ALS. An exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.19172.","journal-title":"Br J Dermatol."},{"key":"461_CR62","doi-asserted-by":"publisher","unstructured":"Jabbehdari S, Memar OM, Caughlin B, Djalilian AR. Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review. Eur J Ophthalmol. 2020. https:\/\/doi.org\/10.1177\/1120672120937252.","DOI":"10.1177\/1120672120937252"},{"key":"461_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.11.045","author":"A Vazirnia","year":"2019","unstructured":"Vazirnia A, Wat H, Danesh MJ, Anderson RR. Intense pulsed light for improving dry eye disease in rosacea. J Am Acad Dermatol. 2019. https:\/\/doi.org\/10.1016\/j.jaad.2019.11.045.","journal-title":"J Am Acad Dermatol."},{"key":"461_CR64","doi-asserted-by":"crossref","first-page":"126531","DOI":"10.1016\/j.jtemb.2020.126531","volume":"61","author":"A Waszczykowska","year":"2020","unstructured":"Waszczykowska A, \u017byro D, Jurowski P, Ochocki J. Effect of treatment with silver(I) complex of metronidazole on ocular rosacea: design and formulation of new silver drug with potent antimicrobial activity. J Trace Elem Med Biol. 2020;61:126531.","journal-title":"J Trace Elem Med Biol"},{"key":"461_CR65","doi-asserted-by":"crossref","unstructured":"Donmez O, Akova YA. Pediatric ocular acne Rosacea: clinical features and long term follow-up of sixteen cases. Ocular Immunol Inflamm. 2019:1\u20139.","DOI":"10.1080\/09273948.2019.1668951"},{"issue":"2","key":"461_CR66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15173","volume":"176","author":"M Schaller","year":"2017","unstructured":"Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):465\u201371.","journal-title":"Br J Dermatol"},{"key":"461_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2020.06.012","author":"LL Graves","year":"2020","unstructured":"Graves LL, Hoopman J, Finn R. Carbon dioxide laser resurfacing for rhinophyma: a case report and discussion of the literature. J Oral Maxillofac Surg. 2020. https:\/\/doi.org\/10.1016\/j.joms.2020.06.012.","journal-title":"J Oral Maxillofac Surg."},{"issue":"3","key":"461_CR68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1203475420906774","volume":"24","author":"L Schmitz","year":"2020","unstructured":"Schmitz L, Hessam S, Scholl L, Reitenbach S, Segert MH, Bechara FG. Wound care with a porcine extracellular matrix after surgical treatment of rhinophyma. J Cutan Med Surg. 2020;24(3):253\u20138.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"461_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40257-017-0310-0","volume":"19","author":"RK Walsh","year":"2018","unstructured":"Walsh RK, Endicott AA, Shinkai K. Diagnosis and treatment of Rosacea fulminans: a comprehensive review. Am J Clin Dermatol. 2018;19(1):79\u201386.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"461_CR70","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1111\/jdv.15520","volume":"33","author":"M Nowak","year":"2019","unstructured":"Nowak M, Bara\u0144ska-Rybak W, Mehrholz D, Nowicki J. Rosacea fulminans\u2014coincidence of the disease with inflammatory bowel disease. J Eur Acad Dermatol Venereol. 2019;33(6):e247\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"461_CR71","doi-asserted-by":"crossref","first-page":"e13436","DOI":"10.1111\/dth.13436","volume":"33","author":"M Garayar Cantero","year":"2020","unstructured":"Garayar Cantero M, Garabito Solovera E, Aguado Garc\u00eda \u00c1, Valtue\u00f1a J, Ruiz S\u00e1nchez D, Manchado LP. Use of permethrin in the treatment of rosacea fulminans during pregnancy: one case report. Dermatol Ther. 2020;33(3):e13436.","journal-title":"Dermatol Ther"},{"issue":"3","key":"461_CR72","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1097\/MJT.0000000000000903","volume":"27","author":"G Merlo","year":"2020","unstructured":"Merlo G, Cozzani E, Russo R, Parodi A. Dapsone for unresponsive granulomatous Rosacea. Am J Ther. 2020;27(3):e304\u20136.","journal-title":"Am J Ther"},{"issue":"4","key":"461_CR73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/phpp.12463","volume":"35","author":"RC Liu","year":"2019","unstructured":"Liu RC, Makhija M, Wong XL, Sebaratnam DF. Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy. Photodermatol Photoimmunol Photomed. 2019;35(4):280\u20131.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"461_CR74","doi-asserted-by":"crossref","unstructured":"Ansorge C, Technau-Hafsi K. Granulomatous rosacea in a\u00a0lung transplant recipient: A\u00a0possible therapy option in a\u00a0unique group of patients. Hautarzt. 2020;71(2):134\u20138. [Article in German].","DOI":"10.1007\/s00105-019-04479-0"},{"issue":"4","key":"461_CR75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.11622\/smedj.2018047","volume":"59","author":"WL Kok","year":"2018","unstructured":"Kok WL, Oon HH, Giam YC. A case report of granulomatous rosacea of the face. Singap Med J. 2018;59(4):228\u20139.","journal-title":"Singap Med J"},{"issue":"4","key":"461_CR76","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","volume":"78","author":"R Haber","year":"2018","unstructured":"Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol. 2018;78(4):786\u201392.e8.","journal-title":"J Am Acad Dermatol"},{"key":"461_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13587","author":"T Searle","year":"2020","unstructured":"Searle T, Al-Niaimi F, Ali FR. Rosacea and the cardiovascular system. J Cosmetic Dermatol. 2020. https:\/\/doi.org\/10.1111\/jocd.13587.","journal-title":"J Cosmetic Dermatol."},{"issue":"6","key":"461_CR78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clindermatol.2019.07.032","volume":"37","author":"U Wollina","year":"2019","unstructured":"Wollina U. Is rosacea a systemic disease? Clin Dermatol. 2019;37(6):629\u201335.","journal-title":"Clin Dermatol"},{"key":"461_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.113","author":"Q Chen","year":"2020","unstructured":"Chen Q, Shi X, Tang Y, et al. Association between Rosacea and cardiometabolic disease: a systematic review and meta-analysis. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.113.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"461_CR80","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/ijd.14802","volume":"59","author":"KG Thompson","year":"2020","unstructured":"Thompson KG, Rainer BM, Kang S, Chien AL. The skin microbiota as a link between rosacea and its systemic comorbidities. Int J Dermatol. 2020;59(4):513\u20134.","journal-title":"Int J Dermatol"},{"key":"461_CR81","doi-asserted-by":"crossref","first-page":"7015249","DOI":"10.1155\/2020\/7015249","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Guo L, Hao D, Li X, Wang Y, Jiang X. Association between Rosacea and cardiovascular diseases and related risk factors: a systematic review and meta-analysis. Biomed Res Int. 2020;2020:7015249.","journal-title":"Biomed Res Int"},{"issue":"6","key":"461_CR82","first-page":"611","volume":"17","author":"PJ Kallis","year":"2018","unstructured":"Kallis PJ, Price A, Dosal JR, Nichols AJ, Keri J. A biologically based approach to acne and Rosacea. J Drugs Dermatol. 2018;17(6):611\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"461_CR83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5935\/0004-2749.20180093","volume":"81","author":"B Bilgin","year":"2018","unstructured":"Bilgin B, Karadag AS. Effects of combined oral doxycycline and topical cyclosporine treatment on ocular signs, symptoms, and tear film parameters in rosacea patients. Arquivos Brasil Oftalmol. 2018;81(6):466\u201370.","journal-title":"Arquivos Brasil Oftalmol"},{"key":"461_CR84","doi-asserted-by":"crossref","unstructured":"Ebneyamin E, Mansouri P, Rajabi M, Qomi M, Asgharian R, Azizian Z. The efficacy and safety of permethrin 2.5% with tea tree oil gel on rosacea treatment: a double-blind, controlled clinical trial. J Cosmetic Dermatol. 2020;19(6):1426\u201331.","DOI":"10.1111\/jocd.13177"},{"issue":"1","key":"461_CR85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jocd.12982","volume":"19","author":"HH Kwon","year":"2020","unstructured":"Kwon HH, Jung JY, Lee WY, Bae Y, Park GH. Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low-dose isotretinoin. J Cosmetic Dermatol. 2020;19(1):105\u201311.","journal-title":"J Cosmetic Dermatol"},{"issue":"4","key":"461_CR86","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2018.09.039","volume":"80","author":"H Lev-Tov","year":"2019","unstructured":"Lev-Tov H, Rill JS, Liu G, Kirby JS. Trends in utilization of topical medications for treatment of rosacea in the United States (2005\u20132014): a cohort analysis. J Am Acad Dermatol. 2019;80(4):1135\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"461_CR87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jid.2019.08.436","volume":"140","author":"NN Kulkarni","year":"2020","unstructured":"Kulkarni NN, Takahashi T, Sanford JA, et al. Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression. J Invest Dermatol. 2020;140(3):645-55.e6.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"461_CR88","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/jocd.13254","volume":"19","author":"N Altunisik","year":"2020","unstructured":"Altunisik N, Turkmen D, Sener S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation. J Cosmetic Dermatol. 2020;19(8):2105\u20138.","journal-title":"J Cosmetic Dermatol"},{"issue":"11","key":"461_CR89","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","volume":"151","author":"N Aldrich","year":"2015","unstructured":"Aldrich N, Gerstenblith M, Fu P, et al. Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol. 2015;151(11):1213\u20139.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"461_CR90","first-page":"663","volume":"144","author":"MA Mc Aleer","year":"2009","unstructured":"Mc Aleer MA, Lacey N, Powell FC. The pathophysiology of rosacea. G Ital Dermatol Venereol. 2009;144(6):663\u201371.","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"461_CR91","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.abd.2019.03.002","volume":"94","author":"P Incel Uysal","year":"2019","unstructured":"Incel Uysal P, Akdogan N, Hayran Y, Oktem A, Yalcin B. Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea. An Bras Dermatol. 2019;94(6):704\u20139.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"461_CR92","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bjd.18616","volume":"182","author":"B Elewski","year":"2020","unstructured":"Elewski B. Rosacea treatment: a patient-centric approach. Br J Dermatol. 2020;182(5):1090\u20131.","journal-title":"Br J Dermatol"},{"issue":"7","key":"461_CR93","first-page":"608","volume":"18","author":"A Cices","year":"2019","unstructured":"Cices A, Alexis AF. Patient-focused solutions in Rosacea management: treatment challenges in special patient groups. J Drugs Dermatol. 2019;18(7):608\u201312.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"461_CR94","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjd.16815","volume":"179","author":"J Tan","year":"2018","unstructured":"Tan J, Berg M, Gallo RL, Del Rosso JQ. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179(3):741\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"461_CR95","first-page":"8","volume":"5","author":"S Diamantis","year":"2006","unstructured":"Diamantis S, Waldorf HA. Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol. 2006;5(1):8\u201312.","journal-title":"J Drugs Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13555-020-00461-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T06:09:34Z","timestamp":1723874974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-020-00461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00461-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}